.:: TuttoCongressi ::.

Hai dimenticato la password? | Registrati

E-mail

Password

Resta Collegato

Cerca per parole nell'archivio:

In archivio:

N° Relazioni: 792
N° Accessi Relaz.: 155876

ISGE 2006

02/03/2006 - 05/03/2006

	Programma Evento
	Info

Mostra tutti | Mostra contenuti EasyRec

Salata I.
Serum Concentrations of Matrix Metalloproteinases (MMP-2, MMP-9) And Their Inhibitors (TIMP-1, TIMP-2) Do Not Reflect The Severity of Endometriosis

Scarselli G.
Abnormal uterine bleeding: diagnosis and treatment

Schenker J.
Prolactinomas, clinical manifestations and treatment

Schilling A.
The efficacy and safety of ethinylestradiol/chlormadinone acetate (Belara®): Results of a non-interventional trial in four Latin-American countries

Schindler A.
Mode of application of GnRH agonists for the treatment of endometriosis

Schneider H.
The role of androgens and antiandrogens

Seaman H.
The risk of venous thromboembolism amongst women with polycystic ovary syndrome

Serfaty D.
Le CIRC (Centre International de Recherche contre le Cancer) et la cancérogénécité de la pilule

Shoham Z.
Reproductive outcome in women with body weight disturbances

Simoncini T.
How steroid signaling in vascular cells predicts the clinical effects of HRT

Simoncini T.
Are progestins all the same? Lessons from the vascular system

Siseles N.
Perimenopausal contraception

Sismondi P.
.

Sismondi P.
Antihormones in prevention and treatment of breast cancer

Sitruk Ware R.
Implants contraceptifs pour homme et pour femme

Skouby S.
Epidemiology and treatment of PMS/PMDD

Skouby S.
Steroid hormone use in insulin resistant women: clinical issues

Soares A.
Effects of coasting on assisted reproduction outcome

Speroff L.
Transdermal vs Oral Postmenopausal Hormone Therapy. Is There a Clinical Difference?

Speroff L.
The Future of Postmenopausal Hormone Therapy It's Time to Move Forward

Spinola P.
Clinical acceptability of injectable contraceptives

Spinola P.
Long-lasting contraception

Spritzer P.
Calpain-10 gene UCSNP-43 and UCSNP-19 polymorphisms in polycystic ovary syndrome (PCOS)

Stefanidis K.
Oxytocin receptor and TRA-1-81 antigen expression in amniotic fluid cells

Stevenson J.
Oestradiol 17β plus cyclical dydrogesterone HRT and its effect on lipid parameters

Stevenson J.
Cardiovascular health after menopause: lessons learnt for clinical practice

Stjernholm Y.V.
Mitogen activated protein kinase signaling pathways are activated in human uterine cervix at parturition

Stomati M.
Effects of low-dose oral deydroepiandrosterone (DHEA) in postmenopausal women

Studd J.
Hormonal treatment of severe premenstrual syndrome

Sturdee D.
The merits of intrauterine progestogen

Szamatowicz M.
"Theft" of the reproductive time of women as a result of unproper treatment of infertility

Szekeres-Bartho J.
How do the immunological aspects of dydrogesterone impact normal pregnancy?

Szilagyi A.
Three dimensional (3D) ultrasound in patients with polycystic ovary syndrome (PCOS); effects of metformin treatment on ovarian volume and blood flow